We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$869B
AUM Growth
+$32.9B
Cap. Flow
-$6.92B
Cap. Flow %
-0.8%
Top 10 Hldgs %
33.83%
Holding
3,059
New
82
Increased
1,782
Reduced
864
Closed
51

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$2.31B
2
AAPL icon
Apple
AAPL
+$1.58B
3
SHW icon
Sherwin-Williams
SHW
+$1.37B
4
HUBS icon
HubSpot
HUBS
+$1.32B
5
KVUE icon
Kenvue
KVUE
+$1.25B

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.37B
2
LRCX icon
Lam Research
LRCX
+$1.54B
3
AMAT icon
Applied Materials
AMAT
+$1.33B
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.19B
5
HAL icon
Halliburton
HAL
+$1.16B

Sector Composition

Rank Sector Weight
1 Technology 32.32%
2 Healthcare 15.15%
3 Financials 10.54%
4 Consumer Discretionary 10.48%
5 Communication Services 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTCI icon
2926
FTC Solar
FTCI
$38.8M
$47K ﹤0.01%
6,810
LTRX icon
2927
Lantronix
LTRX
$275M
$47K ﹤0.01%
11,200
NAUT icon
2928
Nautilus Biotechnolgy
NAUT
$114M
$46K ﹤0.01%
16,078
VSTM icon
2929
Verastem
VSTM
$629M
$46K ﹤0.01%
+15,261
New +$41.4K
MYPS icon
2930
PLAYSTUDIOS Inc
MYPS
$67.3M
$45K ﹤0.01%
29,395
+4,279
+17% +$7.53K
OPAD icon
2931
Offerpad Solutions
OPAD
$22.5M
$45K ﹤0.01%
1,093
AHT
2932
Ashford Hospitality Trust
AHT
$19.8M
$44K ﹤0.01%
5,850
AP icon
2933
Ampco-Pittsburgh
AP
$190M
$44K ﹤0.01%
21,600
MNOV icon
2934
MediciNova
MNOV
$65.5M
$44K ﹤0.01%
20,700
COOK icon
2935
Traeger
COOK
$172M
$43K ﹤0.01%
229
IDN icon
2936
Intellicheck
IDN
$74.7M
$43K ﹤0.01%
19,500
IQ icon
2937
iQIYI
IQ
$1.28B
$43K ﹤0.01%
14,900
LUNA
2938
DELISTED
Luna Innovations Incorporated
LUNA
$43K ﹤0.01%
17,915
BRN icon
2939
Barnwell Industries
BRN
$13.9M
$42K ﹤0.01%
18,200
CHRS icon
2940
Coherus Oncology
CHRS
$181M
$42K ﹤0.01%
40,169
+2,421
+6% +$3.32K
PRPH
2941
DELISTED
ProPhase Labs
PRPH
$42K ﹤0.01%
1,730
ALTI icon
2942
AlTi Global
ALTI
$457M
$41K ﹤0.01%
10,867
PAYS icon
2943
Paysign
PAYS
$723M
$41K ﹤0.01%
+11,100
New +$50.6K
WW
2944
DELISTED
WW International
WW
$40K ﹤0.01%
45,100
-12,700
-22% -$12.3K
EVEX icon
2945
Eve Holding
EVEX
$948M
$39K ﹤0.01%
+12,009
New +$36.3K
MVST icon
2946
Microvast
MVST
$354M
$39K ﹤0.01%
154,200
PRCH icon
2947
Porch Group
PRCH
$1.83B
$39K ﹤0.01%
24,967
QIPT
2948
DELISTED
Quipt Home Medical
QIPT
$38K ﹤0.01%
12,829
WVVI icon
2949
Willamette Valley Vineyards
WVVI
$11.5M
$38K ﹤0.01%
10,850
XFOR icon
2950
X4 Pharmaceuticals
XFOR
$425M
$38K ﹤0.01%
1,867
+193
+12% +$4.03K

Similar funds

T. Rowe Price Associates's Q3 2024 Portfolio in Review

As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
  • T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
  • T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
  • T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
  • T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
  • T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
  • T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.

Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.